Stocks and Investing Stocks and Investing
Thu, October 14, 2021

Andrew Berens Initiated (CCCC) at Buy and Held Target at $67 on, Oct 14th, 2021


Published on 2024-10-27 18:09:41 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Initiated "C4 Therapeutics, Inc." (CCCC) at Buy and Held Target at $67 on, Oct 14th, 2021.

Andrew has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Bradley Canino of "Stifel" Initiated at Hold and Held Target at $45 on, Thursday, September 30th, 2021


This is the rating of the analyst that currently disagrees with Andrew


  • Leah Cann of "Brookline Capital" Initiated at Strong Buy and Held Target at $54 on, Thursday, June 24th, 2021
Contributing Sources